The 2-Minute Rule for ABBV-744 and other BRD4 inhibitors comparison
In Segment C, participants will acquire ABBV-744 and oral navitoclax. In Segment D, members will acquire ABBV-744 and ruxolitinib. Participants will get treatment right until disorder progression or even the members are unable to tolerate the study drugs.Celastrol was determined like a Myb inhibitor that suppressed C/EBPβ action and repressed AML